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INTRODUCTION 
Pregnancy and childbirth are crucial events in almost every woman’s life. 
The maintenance of good maternal health during the period of pregnancy is not 
only essential for the woman’s health, but also has beneficial effects on delivery 
and the woman can give a healthy baby to the society. Normal pregnancy is 
associated with a number of physiological changes in maternal homeostasis. 
Pregnancy is marked by physical and metabolic adaptations. There will be an 
altered lipid metabolism and lipid profile status at the time of pregnancy, when 
compared to the pre- pregnant status. During this period, there is adipose tissue 
expansion and the hepatic lipid synthesis increases. The pregnant woman will 
develop peripheral insulin resistance and alteration of hormones, those directly 
involved in the lipid metabolism such as leptin and insulin are higher than the non 
pregnant state. Consequently , all serum lipid fractions progressively increase, 
some of them up to two fold. These changes are essential for  adequate fetal 
development and growth. 
LIPIDS: 
 Fat is the major storage of energy for the body and contains a large source of 
fatty acids. The excessive fat is stored in the subcutaneous tissue, adipose tissue, 
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retroperitoneal spaces and omentum. Fat serves to protect the body from extreme 
cold and heat. 
Lipids may be regarded as organic substances relatively insoluble in water, soluble 
in organic solvents ( alcohol, ether etc), actually or potentially related to fatty acids 
and utilized by the living cells. 
Lipids are an efficient fuel for all the tissues except brain. In fact, the fatty acids 
are the preferred fuel for heart. 
 
Fig. 1: Saturated and Unsaturated Fatty acid 
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LIPOPROTEIN: 
 Lipoproteins are made up of  lipids and proteins. The proteins of lipoproteins 
are called apolipoproteins. The two major functions are they transport lipids to the 
liver and the different lipids are delivered to the different tissues via the 
lipoprotein. 
STRUCTURE AND CLASSIFICATION: 
 The lipoprotein consists of  two portions named shell and core. The core 
consists of triglyceride and it is the central part. The shell is the coat containing 
apolipoproteins, free cholesterol and phospholipid molecule. Lipoproteins are 
classified as Chylomicrons, very low density lipoprotein, intermediate density 
lipoprotein, low density lipoproteins, high density lipoprotein. 
SERUM LIPID PROFILE: 
 The parameters of serum lipid profile include Total Cholesterol, HDL 
cholesterol, LDL,VLDL cholesterol and Triglyceride. Serum lipid level is an 
important risk factor in the development of PIH, GDM, LGA and Preterm birth. 
Pre-pregnancy obesity promotes metabolic dysregulation and impairies the 
physiological adaptations of pregnancy, thereby increasing the adverse outcomes 
for both the mother and the foetus. 
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Factors affecting the lipid profile: 
1. Reduced physical activity 
2. Excessive weight gain 
3. Unhealthy food habits 
4. Insulin resistance 
5. Alcohol and Smoking habits 
6. Stress 
High lipid profile is the major factor behind atherosclerosis. Lipid profile 
studies have to be done during all the 3 trimesters to rule out the effect of 
pregnancy on the lipid profile. 
Some of the following changes in maternal metabolism occurs in the first 
trimester of pregnancy(Ref: Kalkhoff RK et al,). 
1. Rise in serum levels of oestrogen and progesterone 
2. Rise in insulin secretion due to pancreatic β cell hyperplasia. 
Increased insulin causes peripheral utilization of glucose which results in 
decrease in serum glucose level and increased glycogen storage  in muscle 
and liver. This also increases the storage of fat and there will be decline in 
lipolysis also. 
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 In 2
nd
 and 3
rd
 trimesters the maternal metabolic adjustments occurs, 
which results in sparing of glucose and there is increase in serum fatty acids 
leading to increased risk of Gestational diabetes mellitus and Hypertension 
in pregnancy respectively. 
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AIM 
AIM: 
To estimate the lipid levels in pregnancy and determine whether it is 
associated with pregnancy complications. 
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OBJECTIVE OF THE STUDY 
 PRIMARY OBJECTIVE – To study the lipid profile in pregnancy in the third 
trimester of pregnancy. 
SECONDARY OBJECTIVE – To correlate the same with the pregnancy 
complications and neonatal outcome. 
INCLUSION CRITERIA: 
 Low risk antenatal mothers 
 Woman with singleton pregnancy 
EXCLUSION CRITERIA: 
 Woman age group > 40 years (considered to be high risk) 
 Women with chronic non communicable disease and infectious 
disease 
 Women who are on medications that alters lipid profile (e.g, steroid, 
insulin, thyroid hormones, protease inhibitor, anticonvulsants, 
diuretics.) 
 Multifoetal pregnancy 
  
8 
EVALUTIONAL PLAN: 
All pregnant women attending antenatal clinic in the first trimester who are 
low risk patients will be included in this study. At early third trimester around 32 
to 34 weeks after getting the informed consent from the patient lipid profile test is 
performed and they are monitored till delivery. The collected data will be analyzed 
and important findings of the study will be highlighted.  
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REVIEW OF LITERATURE 
LIPIDS:  
Lipids are insoluble in water and soluble in benzene, chloroform, ether, hot 
alcohol. Many functions are there for lipids, it acts as a storage form of energy, 
gives the contour of the body, helps in the absorption of vitamin A,D,E and K. 
Protect the internal organs with cushioning effect, and act as a surfactant, enhance 
the taste of the food. 
Lipids are classified into : 
1) Simple lipids (triglycerides, waxes) 
2) Compound lipids ( phosphorylated and non phosphorylated ) 
3) Derived lipids (fatty acids, steroids, prostaglandins, leukotrienes) 
4) Lipids complexed and others (proteolipids and lipoproteins) 
The excessive fat in the body will result in obesity, mainly the truncal 
obesity will result in the heart attack. 
Lipid metabolism deranged in diabetes mellitus which results in ketosis 
formation. 
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CLINICAL DISEASES: 
Elevated cholesterol will result in atherosclerosis which leads to myocardial 
infarction and cerebral stroke. 
Excessive intake of cholesterol will end up in obesity which has a risk of 
developing several risks those include cancer, systemic hypertension, diabetes 
mellitus, heart attack , etc. 
Low level cholesterol causes serious disorders, such as deficiency of lung 
surfactant, which result in acute respiratory distress in the newborn babies. 
FATTY ACIDS: 
 
Fig. 2 :Structure of a fatty acid 
It is very important component of lipid. The common fatty acids which are 
found in our body, such  asPalmitic acid and Oleic acid.  
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Essential fatty acids: 
The name itself implicate that it is essential in our body which is otherwise 
called PUFA. This is important for the normal  many cellular functions of the 
body. 
Arachidonic acid is synthesized from the linoleic acid so it is not considered 
as true essential fatty acid, since the linoleic acid itself is essential, the arachidonic 
acid also consider it as essential fatty acid. 
Significance of PUFA: 
1. Arachidonic acid gives eicosanoids which are prostaglandins, leukotrienes 
and thromboxanes which has very important work in our body. 
2. Fish oil which is rich in eicosapentaenoic acid which has significant role in 
preventing atherosclerosis. 
Membrane phospholipids  have many biological important functions which 
are derived from arachidonic acid. 
1) Long term deficiency of PUFA will result in following disorders 
 Reproductive disorders 
 Poor growth 
 Retinitis pigmentosa 
 Dermatitis 
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Animal fats and plant oils: 
Fats of animal origin usually rich in saturated fatty acid.e.g, Butter , meat and 
tallow etc.Plant oil which is rich in unsaturated fatty acid.Where as in coconut oil, 
it contains high saturated fatty acid.fish oil contains unsaturated fatty acid so it has 
low melting point. 
Triglycerides: 
The fats and oils are the esters of fatty acids, which is glycerol. It is otherwise 
called as triacylglycerol or triglycerides. 
Properties of triglycerides: 
1. It is a precursor for complex lipids like glycerophospholipids. 
2. It is concentrated anhydrous forms of fat. It has a high calorific value- 9 
cal/g. It is the major form of storage.  
3. Solid at room temperature. It has a high melting point. 
4. It is hydrolysed by lipase.  
5. During starvation, triglycerides are hydrolysed and converted to glycerol 
and fatty acids. Then, they are oxidized to produce energy. This is called 
as lipolysis. 
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Phospholipids: 
         Phospholipids are derived from phosphatidic acid. The phosphoric acid in it 
is esterified to 1,2, diacylglycerol, this usually being a PUFA. 
The classification of phospholipids: 
1. With nitrogenous base: 
a. Lecithin-phosphatidyl choline 
b. Cephalin-phosphatidyl ethanolamine 
c. Plasmalogens 
d. Phosphatidyl serine 
2. Without nitrogenous base: 
a. Phophatidylinositol 
b. Diphosphatidylglycerol(cardiolipin) 
3. Sphingolipids – containing sphingosine 
a. Sphingomyelin 
4. Glycosphingolipids – containing sphingosine and sugars 
a. Cerebrosides and gangliosides 
The significance of dipalmitoyl lecithin: 
Infant respiratory distress syndrome(IRDS) in newborns is due to the deficient 
production of surfactants. This occurs in about 1% of the newborns. The features 
that follow are tachypnea and tachycardia which may progress to cyanosis and 
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respiratory failure. This is much more common in premature infants. The 
phospholipids that line the alveolar cells are mostly composed of dipalmitoyl 
lecithin which is produced by the epithelial cells at around 20 weeks of pregnancy. 
This surfactant decreases the surface tension and hence prevents the collapse of 
alveoli during expiration. Treatment involves CPPV, maintenance of electrolyte 
and fluid balance. Natural and synthetic surfactants are also used in treatment.  
Importance of Phospholipids: 
1. These are constituents of the cell membrane, the most important being 
lecithin, cephalin and phosphatidylserine. 
2. Mitochondrial membrane comprises of cardiolipin 
3. They are also involved in cell signaling and hormone action, especially 
phosphatidylinositol. 
4. Arachidonic acid which is released by the action of phospholipases on the 
cell membranes play a role in the production of eicosanoids that act as local 
hormones. 
Sphingolipids: 
 These comprise an amino-alcohol called Sphingosine. It is synthesized from 
palmitic acid and serine. Ceramide being the unit of sphingolipids is used to 
synthesiseSphingomyelin and glycosphingolipids. 
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Fig. 4: Metabolism of Sphingolipids 
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Cholesterol: 
Cholesterol is derived from a complex ring called cyclopentano-perhydro-
phenanthrine ring, which has 19 carbon atoms. CPPP ring is modified in such a 
way that an alcohol group is attached at the 3
rd
 position, an 8 carbon side chain is 
attached at the 17
th
 position, and a double bond is formed between the 5
th
 and 6
th
 
carbon atoms, to form cholesterol. It is found in animal fats and not in plants.  
 
Fig.5: Structure of Cholesterol 
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Significance of Cholesterol: 
Cholesterol is present in all the tissues, but it is highly concentrated in the nervous 
tissue and cell membranes.  Several steroid hormones, such as sex steroids, 
glucocorticoids, mineralocorticoids, etc. are derived from cholesterol, along with 
Vitamin D3 and bile acids. The normal cholesterol level is from 150-200 mg%.  If 
the cholesterol is elevated, it may result in coronary artery disease, atherosclerosis 
and cerebral stroke. 
Lipoproteins: 
Lipoproteins are made up of lipids and proteins, which are also known as 
apolipoproteins. There are several main classes of lipoproteins. Every lipoprotein 
contains all types of lipids, but they have one dominant lipid.  
Classes of lipoproteins: 
1. Chylomicrons 
2. Very low density lipoproteins (VLDL) 
3. Low density lipoproteins (LDL) 
4. High density lipoproteins (HDL) 
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Lipoproteins Lipid % Proteins % 
Chylomicron 98-99% 1-2% 
VLDL 90-93% 7-10% 
LDL 79% 21% 
HDL 43-68% 32-57% 
 
Lipoprotein structure: 
It is comparable to that of the micelle, with the outer layer being made of 
phospholipids and free cholesterol. The inside core is made of hydrophobic lipids 
such as glycerol esters. 
Apoproteins are present in lipoproteins as integral and peripheral proteins.  
The proportion of different lipids are different in different lipoproteins. HDL and 
LDL have cholesterol as the main component while chylomicrons and VLDL have 
triacylglycerol as the main lipid. 
Apoproteins are those proteins that are present in lipoproteins. There are at least 10 
known types of apoproteins. These are essential in the composition of lipoproteins. 
They also act as ligands for  the receptors of lipoproteins. They also act as co 
factors for enzymes.  
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These apoproteins are involved in the synthesis of chylomicrons. These are packed 
into chylomicrons within intestinal mucosal cells for the purpose of transport into 
various other tissues. Lipids are synthesized in the smooth endoplasmic reticulum, 
whereas apoproteins are synthesized in the rough endoplasmic reticulum. These 
chylomicrons are rapidly metabolized in the peripheral tissues mainly by muscles 
and adipose tissue. These are acted upon by lipoprotein lipase and the 
triacylglycerols present in the chylomicrons are hydrolysed. The released fatty 
acids and glycerol is taken up by the cells for their use. The chylomicrons then are 
called as chylomicron remnant.  
VLDL synthesis and metabolism are again similar to that of the chylomicrons. 
These are produced in the liver and then transported out to the blood via the 
sinusoids. These are composed of triacylglycerol, cholesterol esters and 
phospholipids. This also is acted upon by lipoprotein lipase and it progressively 
shrinks in size on successive hydrolysis. The fatty acids thus released are then 
taken up by the peripheral tissues. It is then called as the VLDL remnant and they 
become IDL(Intermediate Density Lipoprotein) on further action of LPL.  
LDL is obtained from IDL by the further action of LPL, removing triacyl glycerol. 
LPL acts on the remnant molecules but not on chylomicrons or VLDL per se. LDL 
molecules are also produced in the liver and then secreted into the blood from 
there. The major LDL content is metabolized in the liver, while the rest in tissues 
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particularly involved in sex hormone steroidogenesis. LDL receptors are present on 
most of the cells surfaces in clathrin coated pits. They are most abundantly found 
in the liver cells, adrenals, sex glands, fibroblast, smooth muscle vascular 
endothelial cells and lymphocytes. LDL molecule binds to this receptor and it gets 
internalized to form an endocytic vesicle which forms the endolysosome on fusion 
with the lysosome. The hydrolases that are present in the lysosome cause 
hydrolysis and release proteins into amino acids and free cholesterol and fatty 
acids from cholesterol esters. The expression of the LDL receptors is regulated by 
the availability of intracellular LDL. In times where the internal levels of LDL are 
less, the LDL receptor expression is up regulated and vice versa. LDL plays an 
important role in the formation of Foam cells which is nothing but macrophages 
that express LDL receptors. These receptors in turn cause the macrophages to 
phagocytose LDL. These cells play are significant in the process of atherosclerosis. 
HDL is synthesized both in the lived and in the intestines. The HDL produced in 
each organ has its own appropriate apoproteins and are different from each other.  
Hepatic HDL contains Apo A, Apo C IIand Apo E and does not contain much lipid 
in its core whereas the Intestinal HDL contains only Apo A. These HDL molecules 
when produced are called as nascent HDL and these are acted upon by 
LCAT(Lecithin Cholesterol Acyl Transferrase). The LCAT gets activated by the 
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apoproteins in the HDL and then cause hydrolysis, releasing a fatty acids leading 
to the formation of esterified cholesterol and lysolecithin.  
 
Fig 6: Sources of cholesterol 
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The cholesterol molecule moves into the cell for further metabolism and takes up a 
huge spherical shape on account of addition of more nascent HDL. The further 
removal of triacylglycerol by endothelial lipase during circulation almost depletes 
the lipids of HDL and produces nearly lipidlessapoprotein A1. 
Cholesterol is formed from Lanosterol in the endoplasmic reticulum in a sequence 
of events. Cholesterol is converted into esterified cholesterol by hydrolysis with 
long chain fatty acids usually with oleic acid and this reaction 
in the endoplasmic reticulum is catalyzed by ACAT enzyme. Cholesterol in the 
hepatocytes of the liver is formed into bile salts (cholic acid and chenodeoxycholic 
acid). These are excreted from the liver as conjugated with taurine and glycine. 
When these are present with cations, they are called as bile salts for example 
sodium glycocholate. Secondary bile acids are formed by reactions in the intestine 
by bacteria by the reaction of deconjugation. Bile acids after deconjugation are 
absorbed from the intestine and are recirculated to the liver via the portal vein, 
where they get recirculated. This is regulated by the enzyme 7-α-hydroxylase. 
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Fig 7: Metabolism of HDL cholesterol 
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Fig 8: Cholesterol Pathway 
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Cholesterol is excreted in bile everyday. HMG CoA reductase is the regulatory 
enzyme in the rate limiting step of cholesterol synthesis. There are both short term 
and long term regulatory methods involved in this enzyme expression.  
Mechanism Signal 
HMG-CoA reductase transcription Cellular Cholesterol 
HMG-CoA reductase translation Mavalonate, Dietary Cholesterol, 
Dolichol, Ubiquitin 
HMG-CoA reductase degradation Cellular Cholesterol 
HMG-CoA reductase phosphorylation 
and dephosphorylation 
Insulin, cortisol, Glucagon, Thyroxin 
Reference: Biochemistry by Dr.S.K.Gupta 
The cholesterol balance is maintained in every cell by the intracellular content of 
cholesterol esters. This is possible by regulating the input and the output. During 
times of increased demands for cholesterol, the cells hydrolyse the intracellular 
cholesterol esters thereby giving more room for storing cholesterol esters.Liver is 
the most important organ involved with cholesterol metabolism. It is the major site 
of cholesterol synthesis, regulation and excretion in the body. Vitamin D3, steroid 
hormones and bile acids are some of the significant products of cholesterol. 
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Fig. 9: Regulation of HMG Co A reductase 
Therefore cholesterol plays a significant role in the production of estrogen and 
progesterone, thereby playing a much important role in conception, gestation and 
labour. 
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Serum Lipids in Pregnancy  
Pregnancy is associated with an increase in lipoprotein profiles. These changes 
were first defined by Bacquerel and Rodier but are yet to be discovered in detail. 
All lipoproteins increase markedly in pregnancy. Much of the lipid increase occurs 
in the second and the third trimesters. 
• Total triglycerides raise by 2-3 times   
• Apoprotein-B raises by 56%  
• Total cholesterol increases 50-60% above non-pregnant levels.  
• LDL cholesterol increases by 36%  
• HDL cholesterol increases by 25% in second trimester.  
• Total cholesterol increases by 43%  
• Apoprotein-A increases by 32%  
These changes are gradual, happening by around 25 weeks of pregnancy, peaking 
at term and comes back to normal levels at around 8 weeks post partum. The levels 
of triglycerides, HDL and LDL increase more compared to that of the others. 
VLDL increases 2 to 5 times compared to non pregnant levels. Although LDL 
drops initially, it increases gradually throughout pregnancy peaking to about 45-
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50% and remains elevated even after 8 weeks of delivery despite lactation. HDL 
rises to peak level at mid gestation. HDL2 increases while HDL3 stays the same. 
Therefore post partum measurements of lipids have to be done after 6 months.  
This physiological increase in lipids is very important as it is transferred to the 
fetus and also in placental steroidogenesis. This adaptation by the mother also is 
helpful in maintaining the lipid transfer across placenta.  
The pregnant mother might even have subclinical hyperlipidemia to support this 
cause. 
This rise in the lipid levels are attributed to increased lipogenesis as well as 
hyperplasia. 
The reason behind elevated lipids in pregnancy is not clearly understood but partly 
because of elevated levels of oestrogen, progesterone, and human placental 
lactogen. 
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 Non Pregnant adult 1
st
 trimester 2
nd
 trimester 3
rd
 trimester 
Total Cholesterol <200 141-210 176-299 219-349 
HDL 40-60 40-78 52-87 48-87 
LDL <100 60-153 77-184 101-224 
VLDL 6-40 10-18 13-23 21-36 
Triglycerides <150 40-159 75-382 131-453 
Apolipoprotein A1 119-240 111-150 142-253 145-262 
Apolipoprotein B 52-163 58-81 66-188 85-238 
Reference: William’s Obstetrics, 24th edition 
 
Shitalphuse et al conducted study in shegaon, in Maharastra about the study of 
lipid profile in pregnancy and stated that the ranges of lipids in pregnancy 
especially in 3rd trimester. TC - 270mg/dl, TG -198mg/dl, HDL - 27.6mg/dl, LDL-
195mg/dl.(2) 
Dr. Amit and Dr. Sonagra et al  did study regarding lipids in normal pregnancy  
which was conducted in south India and gave the reports of lipid ranges,  TG-
177±36, TC- 209±33, HDL -40.5±6, LDL- 114±30.(15) 
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Maternal high levels of TRIGLYCERIDES are associated with increased risk of 
GDM, PIH, LGA, Macrosomia, Shoulder dystocia during child birth, preterm, still 
born and also increases the risk of cesarean section. 
An association between early pregnancy triglyceridemia and the subsequent risk of 
preeclampsia, gestational hypertension and preterm deliveries were observed.  
Low level of HDL cholesterol leads to increased risk of GDM and macrosomia. 
High levels of HDL cholesterol gives the protective effect for mother and baby. 
Increase in LDL cholesterol pattern in pregnancy is used to identify women who 
will develop atherosclerosis in later life(Brizzi P et al) 
Many of the study shows that elevated triglyceride level in all the three trimesters, 
but significantly high in GDM mothers. HDL cholesterol is likely less in GDM 
mothers(KK Ryckman et al) 
Abnormal lipid metabolism during pregnancy is the important pathogenesis of 
atherosclerosis, ischemic heart disease, intrauterine growth restriction, and 
hypertension (Brizzi,P).  One of the main factor for perinatal mortality and 
morbidity must be the maternal atherogenic lipid profile early in pregnancy.  
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In early pregnancy there will be elevated TC and TG , in later pregnancy the 
cholesterol is taken up by the placenta and it has important function in foetal 
growth, when it increases abnormally that will end up in LGA babies. 
RaghuRamPusukur et al done study in Mahatma Gandhi mission hospital in 
Navi Mumbai,  200 low risk antenatal mothers were included in this study and 
serum lipid profile was done  in 2
nd
 and 3
rd
 trimesters. They concluded that Total 
cholesterol, LDL and triglycerides are elevated in 2
nd
 and 3
rd
 trimesters. But the 
elevation of lipid profile is more in 3
rd
 trimester when compared to the 2
nd
 trimester 
lipid levels. HDL value is reduced in 3
rd
 trimester than the 2
nd
 trimester.(18) 
Loke D.F et al, conducted a study with  non-pregnant and pregnant women 
and stated that Total cholesterol, triglycerides, LDL levels were elevated more than 
the non-pregnant woman . when comparing the lipid levels in the postpartum 
period of same women they were found to be even more elevated because of 
metabolic changes and diet during and after delivery(19) 
Deepak pachwani et al did study in Gujarat and found that in early 
pregnancy there won’t be any change in lipid profile like non- pregnant woman. 
Total cholesterol, Triglyceride and LDL levels were progressively elevated in 
second and third trimesters. Whereas HDL level will elevate in 2
nd
 trimester and 
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decline in 3
rd
 trimester.(20). Herrera et al suggested that increase in triglyceride 
level provide fuel for mother and saved the glucose for the fetus(21). 
Role of lipids in GDM 
Gestational diabetes mellitus has abundant risk of developing preeclampsia, 
macrosomia, unexplained fetal death, perinatal hypoglycemia, respiratory distress. 
Woman with GDM patients has increased risk of developing Diabetes Mellitus, 
Systemic Hypertension, Cardiovascular disease. 
Diabetes is a systemic disease of metabolism that has varied complications. This 
disease can be classified in pregnancy as,  
1. Pre Gestational Diabetes or Overt diabetes 
2. Gestational Diabetes Mellitus (GDM) 
Gestational Diabetes Mellitus is a disease of pregnancy in which there is impaired 
glucose metabolism which is first noticed during pregnancy. Pregnancy is a pro 
diabetic state in which, the hormones responsible for hyperglycemia are all 
elevated. This adds to the possibility of the woman developing diabetes.  
Obesity is a key factor in the development of diabetes. One major pathology that is 
implicated in the pathogenesis of the disease is: insulin resistance. Insulin is a 
hormone that is secreted by the beta cells of the pancreas that are involved in the 
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mobilization and peripheral utilization of glucose. This is again possible by the 
action of insulin on the SGLT channel present in the muscles.  
In short, the adipose tissue in the abdominal region is metabolically active and 
produces adipokines that impede the action of insulin.  
(Knoop and coworkers) stated that there will be elevated triglyceride and low 
HDL cholesterol in patients with type 2 DM and GDM.During pregnancy the 
placenta acts as an additional storage site for lipids. Women who suffering from 
type1 DM , there was no change in triglycerides but there was low cholesterol level 
because of secondary reduction in HDL.Montelangoand colleagues et al stated that 
there was little change in FFA after 12 hours of fasting.(1) 
AnargyrosKourtis et al conducted a study with 211 pregnant women, OGTT and 
lipid profile were performed  and concluded that woman with elevated sugar levels 
has high levels of Triglyceride. (21) 
Bharathi K. R et al  conducted a case control study in Karnataka,50 pregnant 
women with GDM are taken as case, 50 non GDM patients were taken as control. 
They did lipid profile in all 100 women, in which triglyceride levels were 
significantly elevated and they concluded that Triglyceride level was taken as a 
marker for Gestational diabetes mellitus.(22) 
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Lipids in preeclampsia 
PIH is the multisystem disorder of the pregnancy. it is characterised by elevated 
blood pressure and proteinuria. Incidence of pre eclampsia is 7-10%. The most 
common cause of PIH is oxidative stress which is increased because of altered 
lipid profile. The altered lipid profile will increase the atherogenic LDL and 
Vascular cell adhesion molecules and result in pre eclampsia.(9) 
The maternal triglyceredemia is one of the highest risk factor for developing 
preeclampsia. Many of the study concluded that increased triglyceride level 
significantly increases the incidence of preeclampsia (10) 
Manten et al(2004)., stated that abnormal lipids alter the endothelial function and 
thus leading to the pre eclampia. 50 women with singleton pregnancy are included 
in that study who are not in labour. 10 patients had severe preeclampsia, 20 had 
mild preeclampsia. The total cholesterol, triglyceride and lipoprotein a  values 
were elevated whereas HDL is low than the normal women.(11) 
IA Siddiqui et al stated that high resistance flow to the uterine arteries will result in 
decreased blood supply to the placenta. 
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Pre-eclampsia is a subgroup of disorders under hypertensive disorders of 
pregnancy. They are classified as; 
1. Pregnancy induced Hypertension(PIH) 
2. Pre Eclampsia 
3. Chronic hypertension 
4. Hypertension superimposed pre eclampsia 
5. Eclampsia 
Eclampsia is a convulsive disorder of pregnancy that can occur in the antenatal 
period, during labour or in the puerperium. It is a serious complication and can 
have varied effects on the maternal body and the fetus. 
The effect of lipid profile on hypertension is well documented. An abnormal lipid 
profile is known to have a higher incidence of atherosclerotic disorders in various 
blood vessels causing hypertension. The main pathology that is involved in 
eclampsia is the vasospasm of the spiral areterioles. Abnormal lipid profile is 
associated with a reduced  Prostacyclin and thromboxane A2 ratio. (8) 
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The disorder as such has a plethora of pathology. The important ones are listed 
below: 
1. Abnormal trophoblastic proliferation: 
Trophoblastic invasion is important in the remodelling of the spiral arterioles. 
This occurs erratically in the affected mother. 
2. Immunological factors: 
The anti and the pro angiogenic factors are in a state of complete equilibrium in 
the body, thereby forming new vessels and destroying the old and worn out 
vessels. This mechanism is often seen deranged in the affected mother. This 
can be primary or secondary to maternal infections and chronic diseases such 
as SLE and diabetes mellitus. 
3. Vasospasm: 
In many unexplained cases of PIH, the arteries are often found to be 
susceptible to vasospasm and that can be due to local or systemic factors. Local 
factors involve endothelial activation occurring in atherosclerotic blood 
vessels. 
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Fig 10: Formation of an atherosclerotic plaque 
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4. Nutritional factors: 
A diet higher in fruits and vegetable with more of anti oxidants is found to 
result in a normal blood pressure. An abnormally high blood pressure is also 
seen in obese mothers this often being attributed to formation of plaques. 
5. Genetic factors: 
Eclampsia is a polygenic multifactorial disease. 
In the mother eclampsia can cause the following pathology: 
1. Cardiovascular system: 
Causes ventricular remodelling leading to diastolic dysfunction leading to 
pulmonary edema. 
2. Haematological changes: 
Thrombocytopenia and HELLP syndrome are the common haematological 
abnormalities noted in the eclamptic patient. 
3. Acute Kidney injury 
4. Liver: 
Small haemorrhages are seen in the capsular surface of the liver giving  the 
appearance of a flea bitten liver. 
5. Cerebrovascular Complications: 
Small haemorrhages in the brain are seen in histopathological specimens. 
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Long Term sequelae: 
In a comparison between the normal mothers and those with Hypertensive 
disorders of pregnancy, the latter were found to have a higher incidence of 
ischaemic heart disease.  
They are also susceptible for cerebrovascular accidents in the future. Mothers with 
eclampsia and pre eclampsia are always prone to develop chronic hypertensive 
disease and its complications in the future.  
Preterm delivery: 
Preterm labour is the major cause of perinatal mortality and morbidity because of 
low birth weight babies. 
Preterm delivery is defined as delivery of the foetus before the age of 37 completed 
weeks.Risk factors for preterm labour: cervical insufficiency, previous history of 
preterm delivery, over-distension of the uterus, previous cervical cone biopsy and 
LLETZ, PPROM, multiple surgical termination of pregnancy, infection, 
connective tissue disorders. 
Bacterial infections such as with gonococcal, staphylococcal infections of the 
genitalia, have been found to have been implicated in preterm labour. This is 
attributed to the presence of phospholipase in the bacterial cells. This enzyme 
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hydrolyses the arachidonic acid present in the cell membrane, which releases the 
prostaglandins result in preterm delivery, and it releases the cytokines and 
inflammatory mediators which result weakening of membranes and preterm 
premature rupture of membranes.(3) 
The study found that deficiency of vitamin C, will result in PPROM. When the 
pregnancy advances the plasma levels of ascorbic acid will be reduced which result 
in preterm delivery. In smokers the ascorbic acid level will be low that may the 
contributing factor for PPROM (4). Vitamin C act like co- enzyme for the collagen 
synthesis in the cell membranes which is essential for strength of amniotic 
membrane.(Richasharma and sumita Mehta et al). Daily intake of vitamin C 
100mg/dl after 20weeks of gestation  effectively reduces the incidence of preterm 
premature rupture of membrane. 
Screening for PPROM - which includes transvaginal cervical length and serum 
fibronectin levels.it is not needed in low risk pregnant women since the effective 
interventional strategies have not been identified. 
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LIPID PROFILE AND LGA BABIES: 
Large for Gestational Age(LGA) babies is a term, generally used to describe babies 
that are larger than the appropriate weights for their gestational age. Clinically 
babies that are greater than 90
th
 percentile than their gestational age are termed 
LGA babies. 
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MATERIALS AND METHODS 
This is a prospective study done in the department of obstetrics and 
Gynaecology in PSG Hospitals. We included 200 low risk pregnant womenaged 
<40 years who met the inclusion and exclusion criteria. After obtaining informed 
consent from patients, 4ml of blood withdrawn from the patient in fasting state at 
32 to 34 weeks.Lipid profile assessed by enzymatic end point method, it is 
otherwise called as cholesterol oxidase method. The advantages of method is 
smaller sample quantity is needed, precise, specific, accurate and convenient than 
the conventional lipid assay.  
Low risk women with singleton pregnancy 
 
Explained about the study and informed consent obtained 
 
To do fasting serum lipid profile at 32 to 34 weeks of gestation 
 
Patients are followed up till delivery 
 
43 
Following Maternal and perinatal outcomes which are analysed  
o Preterm labour 
o Pregnancy induced hypertension 
o Gestational diabetes mellitus 
o Birth weight 
o Mode of delivery 
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RESULTS AND ANALYSIS 
Table 1: Age group of study population 
AGE FREQUENCY PERCENTAGE 
<20years 22 11% 
21-25years 88 44% 
26-30 years 69 34.5% 
>30years 21 10.5% 
Total 100 100% 
 
 
In my study, 200 low risk antenatal mother were included, in which 22 
patients were under the age of 20 years, 88 patients under the age of 21-25years, 69 
patients under the age of 26-30 years, and 21 patients of more than 30 years. 
 
  
frequency
<20years
21-25years
26-30years
>30years
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frequency
multi 
primi
Table2: Parity 
PARITY FREQUENCY PERCENTAGE 
Multi 72 36% 
Primi 128 64% 
Total  200 100% 
 
 
 
 
 
 
 
 
 
 
 
In my study, 200  study population were included in which 128 patients 
were primi, 72 patients were multi. 
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Table 3: Classification of study population based on BMI 
BMI FREQUENCY PERCENTAGE 
Underweight  14 7.0% 
Normal  100 50.0% 
Overweight 68 34.0% 
Obese  18 9.0% 
Total  200 100% 
 
 
200 women included in this study were classified into underweight, normal, 
overweight and obese patients. 14 people were in underweight category, 100 
people were in normal BMI, 68 people were overweight, and 18 people were 
obese. 
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Table 4: Lipid Levels 
 
LIPIDS FREQUENCY 
Triglyceride >177 124 
Total cholesterol >209 92 
Low density lipoprotein >114 138 
High density lipoprotein >40.5 183 
 
200 low risk antenatal mother were included in my study, on comparing 
them with the mean value of lipid levels from a South Indian study, 92 patients had 
elevated Total cholesterol >209mg/dl, 124 patients had elevated Triglyceride value 
of more than 177mg/dl, 138 patients had elevated LDL of more than 114mg/dl, 
183 patients had elevated HDL of more than 40.5mg/dl. 
 
 
1, 81
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09
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1, 28
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1, 40
2, 140
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In my study with 200 study population the lipid profile was analysed of 
which the minimum TG value is 81mg/dl, average value is 210mg/dl, and 
maximum is 742mg/dl. The minimum TC value is 122mg/dl, average value is 
209mg/dl and maximum value is 331mg/dl. The minimum HDL value is 28mg/dl, 
average value is 56.89mg/dl and the maximum value is 116mg/dl. The minimum 
LDL value is 40mg/dl, the average value is 140mg/dl, and maximum value is 
257mg/dl. 
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Gestational age at delivery
term
preterm
Table 5: Gestational age at delivery 
 
GESTATIONAL AGE FREQUENCY PERCENTAGE 
Preterm 21 10.5% 
Term 179 89.5% 
Total  200 100.0% 
 
 
 
 
 
 
 
 
 
 
 
In 200 study population 21 patients delivered before 37 weeks, 179 patients 
delivered after 37 weeks of gestation. 
  
50 
Table 6: Classification of study population based on the mode of delivery 
 
MODE OF DELIVERY FREQUENCY PERCENTAGE 
LSCS 61 30.5% 
NVD 118 59.0% 
INSTRUMENTAL 21 10.5% 
Total  200 100% 
 
 
 
 
In my study, 200 low risk antenatal women were included in which 61 
patients were delivered by Cesarean section, 118 patients had normal vaginal 
delivery, 21 patients delivered by instrumental delivery. 
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Table 7: classification of study population based on birth weight 
BIRTH WEIGHT FREQUENCY PERCENTAGE 
AGA 2.5 to3.5kgs 156 78% 
LGA >3.5kgs 12 6.0% 
SGA <2.5kgs 32 16.0% 
Total 200 100.0% 
 
 
 
 
In my study, 156(78%) patients delivered appropriate for gestational age babies 
(2.5-3.5kgs), 12 patients(6%) delivered large for gestational age babies(>3.5kgs), 
and 32 patients (16%) delivered small for gestational age babies(<2.5kgs). 
birth weight
AGA
LGA
SGA
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Table 8: Frequency of preeclampsia in study population 
PREECLAMPSIA FREQUENCY PERCENTAGE 
No 196 98.0% 
YES 4 2.0% 
Total  100 100.0% 
 
 
 
In my study, 200 pregnant women were included in which 4 patients had 
preeclampsia. 
 
 
 
 
 
precelampsia 
yes
No
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Table 9: Frequency of GDM in study population 
GDM FREQUENCY PERCENTAGE 
No  165 82.5% 
Yes 35 17.5% 
Total 200 100.0 
 
 
In my study, 200 pregnant women were included, in which 35 patients 
developed GDM. 
  
Frequency of GDM in study population 
yes
No
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Table9: Frequency of IUGR in the study population 
IUGR FREQUENCY PERCENTAGE 
No 176 88.0% 
Yes 24 12.0% 
Total 200 100.0% 
 
 
 
In my study, 200 antenatal women were included in which 24 patients had 
IUGR. 
 
  
IUGR
NO
YES
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Table 10: Serum cholesterol and pregnancy outcome 
Serum Total 
cholesterol 
mg / dl 
 
Preterm 
 
 
Term 
 
 
 Total 
 
 
Chi 
squared 
value 
P value 
 
 
<209 
 
>209 
12 
 
9 
96 
 
83 
 108 
 
92  
0.005 
 
0.9410 
 
 
<209 
 
>209 
Preeclampsia 
Yes 
Preeclampsia 
No 
  
 
108 
 
92 
 
 
0.026 
 
 
 
 
0.8712 2 
 
2 
 
106 
 
90 
 
<209 
 
>209 
AGA SGA LGA  
108 
 
92 
 
3.7698 
 
0.15184 79 
 
77 
20 
 
12 
9 
 
3 
 
<209 
 
>209 
NVD INSTRUMENT
AL 
LSC
S 
 
108 
 
92 
 
5.8366 
 
0.054 
62 
 
54 
4 
 
11 
42 
 
27 
 
 
<209 
 
>209 
GDM –YES GDM-NO   
108 
 
92 
 
0.050 
 
0.8227 20 
 
15 
88 
 
77 
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Out of 200 pregnant women total cholesterol is elevated in 92 patients in 
which 9 patients had preterm delivery. 2 patients had preeclampsia, 12 patients had 
SGA babies,77 patients had AGA babies,3 patients had LGA babies, 54 delivered 
by normal vaginal delivery, 11 patients delivered by instrumental delivery, 27 
patients delivered by caesarean section and 15 patients had GDM. The association 
of total cholesterol with pregnancy outcome and perinatal outcome is not 
statistically significant. 
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Table 11: serum triglyceride and pregnancy outcome 
Triglyceride 
 
Preeclampsia-
yes 
Preeclampsia-
no 
 Total 
 
Chi 
square 
P value 
 
<177 
 
>177 
1 
 
3 
75 
 
121 
 76 
 
124 
 
0.000 
 
0.9834 
 
TG<177 
 
TG>177 
AGA SGA LGA  
76 
 
124 
 
 
0.9685 
 
 
0.61616 
60 
 
96 
13 
 
19 
3 
 
9 
 
TG<177 
 
TG>177 
NVD Instrumental  LSCS  
76 
 
124 
 
 
1.1563 
 
 
o.5609 
45 
 
73 
10 
 
11 
21 
 
40 
 
Out of 200 study population,92 patients had elevated total cholesterol in 
which the pregnancy outcome and perinatal outcome were analyzed, serum total 
cholesterol level and in correlation with preterm delivery only 9 patients delivered 
before 37 weeks, 83 patients delivered at term. Only 2 patients had preeclampsia, 3 
patients had large for gestational age babies. Out of 200 patients 15 patients had 
GDM, 77 patients had good glycemic control. All these outcomes were analyzed 
and found to be statistically insignificant. 
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Table12: Serum Triglyceride and GDM 
TRIGLYCERIDE GDM- 
yes 
GDM- 
no 
Total  
<177 5 71 76 
>177 30 94 124 
Total 35 165 200 
 
 
 
In my study 200 pregnant women were included in which 124 patients had 
elevated triglyceride, 30 patients had GDM. The chi square test value is 10.197. the 
p value is 0.0014. This study is statistically significant. 
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Table 13: Serum triglyceride and preterm delivery 
TRIGLYCERIDE PRETERM 
DELIVERY 
TERM 
DELIVERY 
TOTAL 
<177 3 73 76 
>177 18 106 124 
Total 21 179 200 
 
 
In my study 200 low risk antenatal mothers were included in which 124 
patients had elevated serum triglyceride, 18 patients had preterm delivery and 106 
patients had delivery at term. The chi squared value is 4.533. the p value is 0.0333. 
the p value is <0.05 so this result is significant. 
 
 
0
20
40
60
80
100
120
TG <177 TG>177
prererm
term
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Table 14: serum LDL and pregnancy outcome 
LDL 
( mg / dl) 
 
Preterm 
 
Term 
 
 Total 
 
Chi 
square  
P value 
 
<114 
 
>114 
5 
 
16 
57 
 
122 
 62 
 
138 
 
0.254 0.614 
 
 
<114 
 
>114 
Preeclampsia
yes 
Preeclampsia 
no 
  
 
62 
 
138 
 
 
1.893 
 
 
0.1688 3 
 
1 
59 
 
137 
 
<114 
 
>114 
GDM-yes GDM-no   
62 
 
138 
 
0.441 
 
0.5067 13 
 
22 
 
49 
 
116 
 
 
 
<114 
 
>114 
AGA SGA LGA  
62 
 
138 
 
4.5306 
 
0.1037 45 
 
111 
10 
 
22 
7 
 
5 
 
 
<114 
 
>114 
NVD INSTRUMENT
AL 
LSC
S 
 
62 
 
138 
 
2.0363 
 
0.361 
37 
 
81 
9 
 
12 
16 
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Out of 200 patients 138 patients had elevated LDL cholesterol value., only 
16 patients had preterm delivery, only one patient developed preeclampsia, 22 
patients had GDM, 5 patients had LGA babies, 45 patients had cesarean sections. 
All the outcomes were analyzed with Serum LDL level and found to have 
statistically insignificant result. 
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Table 14: serum HDL and pregnancy outcome 
HDL  
(mg / dl) 
 
Preterm 
 
 
Term 
 
 
 Total 
 
 
Chi 
square  
 
P value 
 
 
<40.5 
 
>40.5 
1 
 
20 
16 
 
163 
 17 
 
183 
 
 
 
0.056 
 
0.8136 
 
 
 
<40.5 
 
>40.5 
Preeclampsia
-yes 
Preeclampsia –
no 
  
 
 
17 
 
183 
 
 
 
 
0.371 
 
 
 
 
0.5425 
 
0 
 
4 
 
17 
 
179 
 
<40.5 
 
>40.5 
GDM-yes GDM-no   
17 
 
183 
 
 
0.000 
 
 
0.9867 
3 
 
32 
 
14 
 
151 
 
 
<40.5 
 
>40.5 
AGA SGA LGA  
17 
 
183 
 
 
0.7896 
 
 
0.673819 
12 
 
144 
4 
 
28 
1 
 
11 
 
<40.5 
 
>40.5 
NVD INSTRUMENT
AL 
LSC
S 
 
17 
 
183 
 
 
3.1277 
 
 
0.209333 13 
 
105 
2 
 
19 
2 
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The HDL values and pregnancy outcome were analyzed and found to have 
statistically insignificant result. 
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DISCUSSION 
Hyperlipidemia usually occurs in the pregnant woman. If the metabolic changes 
are within normal levels there won’t be any problem throughout the pregnancy, 
when it exceeds the normal range the problem can occur. Due to hyperlipidemia 
atherosis will be seen in the utero placental spiral arteries, this will lead to 
decreased blood supply to the foetus which in turn results in pre eclampsia.  
Pregnancy itself will increase the insulin resistance. In hyperlipidemia, especially 
high BMI patients, the level of insulin resistance will be even more higher and will 
end up in gestational diabetes mellitus. Later they might develop type 2 Diabetes 
mellitus. Patient with dyslipidemia are prone to have Preterm delivery and 
perinatal complications such as small for gestational babies, Large for gestational 
age and  still born. Our study is conducted to determine the association between 
lipid level and pregnancy complications and to create awareness in the society for 
the prevention of adverse pregnancy outcome due to dyslipidemia.    
The study was conducted in PSGIMS&R, in the department of Obstetrics and 
Gynecology, 200 low risk antenatal women were included in this study. Fasting 
lipid profile was done after 8-12 hours of fasting period in 32 to 34 weeks of 
gestation. These patients were followed up until delivery for complications. 
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According to Table 1 more than 90% study population under the age of 30 years, 
and remaining are above 30 years. Maximum age limit in my study is 34 years. 
Deepti G.I et al concluded in their study that there were elevated total cholesterol, 
triglyceride and Low density lipoprotein in older age than the younger  women. 
The reason behind the elevation of lipid profile in older age group is hormonal 
changes especially alteration in the estrogen metabolism  
 In my study there were 200 pregnant women who participated in which 72 
were multigravida. 128 were primigravida. Davit mankuta et al shows that there 
will be decline in the HDL level in primi than the nulliparous women, because the 
pregnancy itself will increase the lipid levels in each trimester. Maternal weight 
gain, maternal nutrition and pre pregnant high cholesterol levels have high impact 
on the lipid profile changes. In their study, they concluded that TC, TG and LDL 
will be elevated in consecutive pregnancy whereas there will be low levels of 
HDL. Low levels of HDL will result in early atherogenic changes in vessels and 
result in coronary artery disease. But there won’t be any great decline in the HDL 
level in consecutive pregnancy.  
According to table 3, the study population is classified based on the BMI. Out of 
200 patients 50% women had normal BMI. Only small proportion of women had 
BMI >30(obese 9%)  and34% of women had overweight. In our study 16 
overweight women developed GDM, two  overweight women had 
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preeclampsia.Out of 18 obese patients, 1 patient had developed preeclampsia,7 
patients had GDM. Shamai L et al explained in their study that high BMI patients 
having elevated levels of total cholesterol and triglyceride levels. High triglyceride 
levels are significantly associated with insulin resistance. So in later age the 
patients with high BMI can go for type2 DM. 
In south India, Amit D. Sonagra et al, conducted a study of lipid profile in pregnant 
women in each trimester and compared the value with non - pregnant healthy  
women of same age group.The mean value of lipid profile  of 3rd trimester women 
in the above study is similar to my study . The mean values from above study are 
TC-209mg/dl, TG-177mg/dl, HDL-40.5mg/dl, LDL- 114mg/dl. These mean values 
of their study is approximately correlates with our study. In our study, the mean 
values of lipid profile are, Total Cholesterol is 209mg/dl, Triglyceride-210mg/dl, 
HDL- 56.8mgdl, LDL -140mg/dl. 
 
In our study according to table 5, out of 200 pregnant women, 21 patients had 
delivery before 37 weeks, 179 patients had delivery after 37 weeks.  
Many of the studies states that, the abnormal lipid profile especially, elevated 
triglycerides will result in preterm delivery and increased risk of developing fetal 
compromise. The atherosis which will develop in patients with abnormal lipid 
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value with superadded hyper coagulable state of pregnancy, the chance of 
developing thrombosis, placental infarction and utero placental insufficiency will 
affect the fetus and result in preterm delivery and small for gestational age babies.  
According to table 6, in total study population (no-200) 118 patients had normal 
vaginal delivery, 21 had instrumental delivery, 61 patients had cesarean section. 
Elahehmossayebi et al  done a study in normal pregnant woman in early third 
trimester and Glycemic changes in third trimester. In patients with Gestational 
diabetes mellitus, the incidence of fetal macrosomia is high. So the chances of 
Cesarean delivery also high.  In our study, total cholesterol is elevated in 92 
patients in which 27 patients had cesarean delivery, Triglyceride is elevated in 124 
patients in which 40 patients had cesarean delivery, High density lipoproterin is 
elevated in 138 patients in which only 45 patients had cesarean delivery. The 
abnormal lipid levels and mode of delivery showed no significant difference in my 
study, so the result is statistically insignificant. 
 
According to table 8,In our study, 200 low risk pregnant women were included in 
which only 4 patients had developed preeclampsia. The number is too small, so 
statistical difference can’t be made out. Tanja G.M et al stated that elevated 
triglyceride will result in GHT, Preeclampsia, preterm delivery, perinatal 
complications such as small for gestational age, large for gestational age, child 
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loss. The reason for preeclampsia is elevated plasma lipid levels especially 
triglyceride levels and its remnants will cause endothelial dysfunction. Increasing 
lipid levels increases the lipid peroxidation thereby the oxidative stress also 
increased. The increasing levels of lipid peroxide will injure the endothelium and 
results in endothelial dysfunction in the placenta which is strongly associated with 
the maternal complications (preeclampsia) and fetal complications (IUGR). 
According to table 9, out of 200 pregnant women in our study, 35 women had 
developed Gestational Diabetes Mellitus. All women who participated in our study 
were screened for GDM at 24-28 weeks. Blood sugar values are repeated in the 3rd 
trimester. 
Glucose intolerance first diagnosed in pregnancy is called as gestational diabetes 
mellitus. The early complications of diabetes mellitus are preeclampsia, fetal 
macrosomia and cesarean delivery. 
According to table12,In our study Total cholesterol was elevated in 92 patients in 
which only 15 patients had GDM. Triglyceride was elevated in124 patients in 
which 30 patients had GDM. In patients with elevated LDL out of 138 population 
only 22 patients had GDM. The relation between triglyceride and GDM showed 
significant result which statistically significant. 
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 KK Ryckman et al conducted  a case control study in Iowa city in USA, 
They divided the study population as a case( pregnant women with GDM), and 
control (pregnant women without GDM). They concluded that the triglyceride 
value is elevated throughout the pregnancy in pregnant woman with GDM and 
HDL cholesterol values were also low, So they observed that dyslipidemia may be 
important in the pathogenesis of GDM.  
According to table 7, Out of 200 low risk pregnant women that were include in our 
study 156 patients delivered appropriate for gestational age babies, 12 patients 
delivered large for gestational age babies, 32 patients delivered small for 
gestational age babies. The abnormal lipid profile and perinatal outcome regarding 
birth weight are not statistically significant. Wen Yuan Jin et al stated that there is 
association between high levels of maternal triglyceride level and large for 
gestational age babies without glycemic intolerance.(7,5) 
According to table 10, out of 200 study population,92 patients had elevated total 
cholesterol in which the pregnancy outcome and perinatal outcome were analyzed, 
serum total cholesterol level and in correlation with preterm delivery only 9 
patients delivered before 37 weeks, 83 patients delivered at term. Only 2 patients 
had preeclampsia, 3 patients had large for gestational age babies. Out of 200 
patients 15 patients had GDM, 77 patients had good glycemic control. All these 
outcomes were analyzed and found to be statistically insignificant. 
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In a study done by IA Siddiqui et al in Saudi Arabia, he concluded that 
Triglycerides will be elevated in Preeclampsia and Gestational Diabetes mellitus, 
but Total cholesterol, HDL and LDL didn’t make much difference in pregnant and 
non -pregnant women.(23) 
According to table 11, In our study out of 200 patients, 124 patients had elevated 
serum Triglyceride in which 3 patients developed preeclampsia.9 patients had 
LGA babies, 40 patients had cesarean delivery. All these outcomes analysed and 
found to be statistically insignificant result.  
Many of the studies stated that elevated triglycerides had important role in 
preeclampsia and GDM(24) 
In our study small number of patients developed preeclampsia(only 4 patients out 
of 200 population). Large sample size is needed to prove the significance of 
triglyceride in preeclampsia. 
In our study out of 200 pregnant women, according to table 13, the triglyceride 
values were elevated in 124 patients in which 18 patients had delivery before 37 
weeks and 106 patients had delivery at term. From our study we concluded that the 
elevated triglyceride level may predispose to preterm delivery which is statistically 
significant 
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According to table 14: the LDL cholesterol and pregnancy outcome were analyzed. 
Out of 200 patients 138 patients had elevated LDL cholesterol value., only 16 
patients had preterm delivery, only one patient developed preeclampsia, 22 patients 
had GDM, 5 patients had LGA babies, 45 patients had cesarean sections. All the 
outcomes were analyzed with Serum LDL level and found to have statistically 
insignificant result. 
According to table 15: The HDL values and pregnancy outcome were analyzed and 
found to have statistically insignificant result. 
BabitaGgidke et al stated that the values of Total Cholesterol, 
HDL,LDL,VLDLcan not predict the occurrence of preeclampsia, GDM and 
preterm deliveries.(24) 
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LIMITATIONS 
The limitation of our study are the lipid profile should be assessed in each 
trimester as it helps in knowing about the increasing levels of lipid in each 
trimester and prevent early and late complications by giving diet control and life 
style modification. In our study lipid profile was done only in 3
rd
 trimester so the 
outcome due to lipid abnormalities cannot be properly analysed. A large number of 
population is required to observe the difference in lipid profile and know its 
outcome. 
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CONCLUSION 
In conclusion out of 200 pregnant women, serum triglyceride is elevated in 
124 low risk pregnant women, in which 30 patients had developed Gestational 
diabetes mellitus and 18 patients had developed pre term delivery. Hence the 
serum triglyceride has been found to be useful simple marker for Gestational 
diabetes mellitus and preterm delivery. Postpartum follow up is necessary in 
patients with dyslipidemia to prevent future complications like atherosclerosis and 
heart disease. Hence certain life style modifications is required in women of 
reproductive age group to lower the lipid levels as it can prevent the hypertensive 
complications in pregnancy, GDM and Preterm delivery. 
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PROFORMA 
NAME: 
AGE: 
OP/IP NUMBER: 
OBSTETRIC SCORE: 
GESTATIONAL AGE: 
COMORBIDITIES: 
LMP: 
EDD: 
WEIGHT: 
HEIGHT: 
BMI: 
WEIGHT GAIN IN PREGNANCY: 
BP READINGS: 
LIPID PROFILE: 
 TOTAL CHOLESTEROL- 
 TRIGLYCERIDES- 
 LDL- 
 HDL- 
ANTENATAL GCT: 
LABOUR DETAILS-           TERM/ PRETERM 
                                               SPONTANEOUS/ INDUCED 
                                                DURATION OF LABOUR 
                                                NVD/ INSTRUMENTAL/ ELECTIVE/             
                                                EMERGENCY LSCS 
BABY DETAILS:                  GIRL/BOY 
                                                BIRTH WEIGHT 
                                                APGAR AT BIRTH 
                                                NICU ADMISSION 
 
 
  
PSG Institute of Medical Science and Research, Coimbatore 
Institutional Human Ethics Committee 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS 
 
(strike off items that are not applicable) 
 
 
I  Dr.S.Geetha,  am carrying out a study on the topic: MATERNAL LIPID 
PROFILE DURING PREGNANCY AND ITS ASSOCIATION WITH 
PREGNANCY COMPLICATIONS as part of my research project being carried 
out under the aegis of the Department of Obstetrics and Gynaecology 
 
My  research guide is: Dr. SeethaPanicker 
 
The justification for this study is:  
To evaluatet the ill effects of abnormal lipid profile on maternal and neonatal 
morbidity and create the awareness of child bearing age group women in society to 
make their parturition period uneventful.  
 
The objectives of this study are:  
 
Primary Objective: To study the lipid profile in pregnancy in all antenatal mothers 
 
Secondary Objective: To correlate the same with pregnancy complications and 
outcome 
 
 
Sample size: 200 
 
Study volunteers / participants : all antenatal low risk women 
 
Location:  PSG hospitals  
 
We request you to kindly co-operate with us in this study. We propose collect 
background information and other relevant details related to this study. We will be 
carrying out:  
 
Initial interview (specify approximate duration): 30 minutes.  
 
Data collected will be stored for a period of >10 years. We will / will not use the 
data as part of another study. 
 
Clinical examination (Specify details and purpose): general examination, all 
system examination in detail.  
 
Blood sample collection: Specify quantity of blood being drawn: 4ml.  
 
No. of times it will be collected: once 
 
Whether blood sample collection is part of routine procedure or for research 
(study) purpose: both  
 
1. Routine procedure 2. Research purpose  
 
Specify purpose, discomfort likely to be felt and side effects, if any: To find out 
the abnormal range of  serum lipid level 
 
Whether blood sample collected will be stored after study period: No, it will be 
destroyed 
 
Whether blood sample collected will be sold: No  
 
Whether blood sample collected will be shared with persons from another 
institution: No 
 
Medication given, if any, duration, side effects, purpose, benefits: no 
 
Whether medication given is part of routine procedure:  No  
 
Whether alternatives are available for medication given:  No  
 
Final interview (specify approximate duration): 30 mts. 
 
Benefits from this study: To know the effects of abnormal lipid profile in 
pregnancy and its outcome 
 
Risks involved by participating in this study: nil 
 
How the results will be used: By identifying the ill effects of abnormal lipid 
profile in pregnancy on maternal and neonatal health, create the awareness of child 
bearing age group women in society to maintain the healthy life style. 
If you are uncomfortable in answering any of our questions during the course of 
the interview / biological sample collection, you have the right to withdraw from 
the interview / study at anytime. You have the freedom to withdraw from the 
study at any point of time. Kindly be assured that your refusal to participate or 
withdrawal at any stage, if you so decide, will not result in any form of 
compromise or discrimination in the services offered nor would it attract any 
penalty. You will continue to have access to the regular services offered to a 
patient. You will NOT be paid any remuneration for the time you spend with us 
for this interview / study. The information provided by you will be kept in strict 
confidence. Under no circumstances shall we reveal the identity of the respondent 
or their families to anyone. The information that we collect shall be used for 
approved research purposes only. You will be informed about any significant new 
findings - including adverse events, if any, – whether directly related to you or to 
other participants of this study, developed during the course of this research which 
may relate to your willingness to continue participation. 
 
Consent: The above information regarding the study, has been read by me/ read to 
me, and has been explained to me by the investigator/s. Having understood the 
same, I hereby give my consent to them to interview me. I am affixing my 
signature / left thumb impression to indicate my consent and willingness to 
participate in this study (i.e., willingly abide by the project requirements).  
 
Signature / Left thumb impression of the Study Volunteer / Legal Representative:  
 
Signature of the Interviewer with date:     
 Witness: 
 
Contact number of PI: 9790481511 
 
Contact number of Ethics Committee Office:  0422 4345818  
NAME AGE OP NO. OBS SCORE GA CO MORB WEIGHT HT BMI WT GAIN TC TG LDL HDL GCT TERM/PRE NVD/LSCS BRT WT STILL BORNPRE ECLAM GDM IUGR
sabeena 21yrs o17099690 primi 33w 44 167 15.8 7 243 134 184 71 121 term nvd aga _ no no no
kowsalya 20yrs o18003366 primi 33w+6d 41 163 16.4 10 122 114 64 52 88 term nvd sga _ no no no
jessina 22yrs o17074818 primi 32w+2d 38 153 16.4 21 331 303 220 82 93 term nvd aga _ no no no
bhuvaneshwari 20yrs o18022315 primi 33w+1 40 158 16.6 8 157 156 106 39 114 term nvd aga _ no no no
rathi 31yrs o18008062 multi 34w+2d previous lscs 43.2 163 16.6 18 192 140 124 71 121 term lscs sga _ no yes yes
shanthi 22yrs o14007933 multi 32w+1d 42 162 17.1 13 144 131 96 43 108 term nvd aga _ no no no
rajalakshmi 20yrs o17000159 multi 33w+6d 42 155 17.5 9 318 267 248 58 97 term nvd aga _ no no no
tharani 23yrs o18007829 primi 34w 44 160 17.6 9 206 149 148 53 84 term lscs sga _ no no no
abirami 26yrs o18013954 primi 34w 42.5 161 17.7 10 249 261 186 47 106 term nvd aga _ no no no
asha devi 22yrs o18028330 primi 33w+4d 66 160 17.7 8 163 311 69 63 133 term nvd aga _ no no no
revathi 19yrs o18048941 primi 32w+5dmild oligohyrominos, anemia39 152 17.7 15 265 180 181 87 112 term nvd aga _ no no yes
latha 26yrs o15004603 multi 32w symmetrical iugr 40 152 18.18 12 223 162 163 54 82 term nvd aga _ no no yes
raji 31yrs o14050755 primi 33w+2d gdm on diet 41.9 151 18.3 14 183 202 123 39 140 term lscs sga _ no yes no
kavitha 28yrs o09004703 multi 33w+4d mild anemia 40.5 151 18.4 10 304 286 220 56 89 term nvd aga _ no no no
pavithra 25yrs o17039810 primi 33w+6d 39 145 18.5 15 213 179 144 70 138 term nvd aga _ no no no
binisiya 20yrs o18027285 primi 32w+6d 63 182 18.5 10 185 295 110 57 124 term nvd aga _ no yes no
nishana parveen 19yrs o18010117 primi 33w+4d 41 150 18.6 10 232 180 152 65 97 term nvd aga _ no no yes
lavanya 25yrs o15005920 multi 34w 45 155 18.7 9 261 174 173 85 86 term nvd aga _ no no no
petchiammal 25yrs o12089989 primi 34w 48.9 160 18.8 15 310 213 229 72 92 term nvd aga _ no no no
vanithamani 23yrs o18005280 primi 33w 41.8 159 19 7 231 228 141 80 92 preterm nvd sga _ no no no
sai dharshini 19yrs o17094263 primi 33w+5d 44 152 19.1 18 241 276 185 38 107 term nvd aga _ no no no
nandhini rajathi 24yrs o17093312 primi 33w+1d pprom 55 167 19.2 9 289 195 216 75 95 preterm lscs aga _ no no no
priyadharshini 18yrs o18026897 primi 33w+3d short stature 37 144 19.4 6 184 134 127 50 95 preterm nvd sga _ no no no
deepika 28yrs o18018732 primi 34w 43 149 19.4 10 201 251 124 53 109 term nvd aga _ no no no
aruna devi 25yrs o16051070 primi 33w+4dlow lying placenta 45 151 19.7 14 184 236 111 47 123 term lscs aga _ no no no
ilakiya 29yrs o13034020 multi 33w+6d previous lscs 47 154 19.8 11 262 190 206 47 86 term lscs aga _ no no no
poomani 27yrs o18009420 primi 32w+4d 43.9 154 19.9 18 171 167 110 46 108 term lscs lga _ no no no
shifana banu 25yrs o12077799 multi 32w 46 157 19.9 10 226 213 149 61 96 term nvd aga _ no no no
chitra 31yrs o18042435 primi 33w 44 155 20 15 167 184 76 74 129 term nvd aga _ no no no
nithya priya dharshini19yrs o18000514 primi 34w 44 159 20 12 178 206 127 41 101 term nvd sga _ no no yes
poongodi 25yrs o15056032 primi 33w+6d 52 165 20 14 234 238 160 66 102 term lscs aga _ no no no
dhanalakshmi 21yrs o17100776 primi 32w+4dlow lying placenta 50 158 20 5 270 120 203 72 100 term lscs sga _ no no no
kousika 20yrs o17097515 primi 32w+4d 50 161 20 9 267 142 187 80 100 term nvd sga _ no no yes
sudha 30yrs o17036539 multi 32w+4d 48 155 20 16 175 139 120 47 146 term nvd aga _ no yes no
nirmala devi 23yrs o17020272 primi 32w+3d 45.5 151 20 10 161 111 109 56 76 term lscs sga _ no no yes
rajeshwari 25yrs o18034077 primi 33w 42 148 20 7 202 334 122 45 105 term nvd aga _ no no no
selvi 24yrs o14065087 primi 32w+3d 45.6 155 20.2 14 185 194 128 47 114 term nvd aga _ no no no
baby shamili 26yrs o17095162 primi 34w 50.6 159 20.2 12 200 201 137 56 115 term lscs aga _ no no no
suganya 25yrs o17067835 primi 34w 51.3 159 20.3 13 175 210 109 47 94 term nvd aga _ no no no
kiruthika o17098488 multi 32w+6d 56 164 20.8 7 190 151 136 49 90 preterm nvd sga _ no no yes
buvaneshwari 27yrs o18019714 primi 32w+4d 50 158 20.8 11 170 203 106 43 81 term nvd aga _ no no no
shapna jasmine 20yrs o18008063 primi 33w 50 163 20.8 20 236 294 159 49 94 term nvd aga _ no no no
ranjitha 26yrs o18038962 multi 33w+2d 46 149 20.9 5 193 169 139 42 105 term nvd aga _ no no no
nirosemmena 20yrs o17096491 primi 34w 40 145 21 8 271 173 229 31 97 preterm nvd sga _ no no yes
madhumitha 27yrs o17079123 primi 32w+6d 50.5 155 21 12 304 393 216 62 95 term nvd aga _ no no no
jessy 23yrs o15008342 primi 33w+1 53 159 21 12 168 139 102 61 86 term nvd aga _ no no no
hidhaya begam 26yrs o18028725 primi 34w 53 160 21.2 9 307 191 257 50 141 term nvd aga _ no yes no
sangeetha 22yrs o17072345 primi 31w+6dborderline oligohydromnios51 155 21.2 13 283 81 209 92 102 preterm nvd sga _ no no yes
dhivya 27yrs o18006349 multi 32w previous lscs 49 152 21.3 14 176 202 106 60 87 term lscs aga _ no no no
yamuna 27yrs o17042316 primi 33w+5danemia treated 52.6 157 21.3 15 221 248 142 61 130 term nvd aga _ no no no
rega 34yrs o17056039 multi 33w+32 60 168 21.3 8 185 298 98 59 83 term nvd lga _ no no no
santhiya arunkumar21yrs o17066944 primi 32W 54 159 21.4 9 229 192 144 70 75 term nvd aga _ no no no
amutha 26yrs o18015685 primi 32w+6dfibroid complicating pregnancy51 154 21.5 7 139 156 70 58 102 term nvd aga _ no no no
abeenaya 30yrs o14027500 multi 33wrh negative, anemia treated, previous lscs57 163 21.5 5 284 194 204 59 98 term lscs aga _ no no no
chandra 29yrs 13005631 multi 32w+6d previous lscs 55 160 21.5 13 157 107 114 43 114 term lscs aga _ no no no
reena 32yrs o18035096 primi 32w+4d gdm on diet 54 160 21.6 16 190 202 109 61 100 term lscs aga _ no yes no
sreen parveen 25yrs o18040260 primi 34w oligohydromnios 46 146 21.6 8 231 155 193 40 87 preterm nvd aga _ no no yes
suganthi 24yrs o17074782 multi 33w+2d previous lscs 45 144 21.7 8 236 201 178 48 154 term lscs aga _ no yes no
kaleeswari 24yrs o15060808 multi 33w+6d 48 149 21.8 8 173 500 64 51 128 term nvd lga _ no yes no
kalpana devi 27yrs o17071797 primi 34w+1d 58 163 21.8 12 167 331 88 37 117 term nvd aga _ no no no
anu 24yrs o18002856 primi 34w+1d 48.3 152 21.9 5 179 178 111 54 126 term nvd aga _ no no no
lavanya 23yrs o17062482 primi 33w+6d anemia 55 158 22 9 226 250 146 61 82 term lscs aga _ no no no
ranjitha 26yrs o18038962 multi 32w+4d 42 149 22.1 9 193 169 139 42 105 term nvd aga _ no no no
silvya jennifer 30yrs o17077538 primi 33w+1d prom 52.4 154 22.1 10 246 233 189 43 104 term lscs aga _ no no no
rohini 26yrs o17081579 primi 34w+2d 51 152 22.1 9 245 341 172 46 121 term lscs lga _ no yes no
sorna soundarya 20yrs 17003217 primi 34w bronchial asthma 53.6 156 22.1 8.5 306 162 234 74 91 term nvd aga _ no no no
gayathri 23yrs o18008241 primi 33w 50.4 150 22.2 9 214 163 160 56 81 term nvd sga _ no yes yes
rajeshwari 20yrs o17093677 primi 33w+1d 49 157 22.2 13 240 299 167 56 112 term nvd aga _ no no no
rohini 25yrs o18020800 primi 34w 58 164 22.3 12 169 213 110 47 105 term nvd lga _ no no no
nithya 22yrs o17066323 primi 33w+2d 55 157 22.3 14 240 253 159 60 101 preterm nvd sga _ no no yes
lashagi devi 24yrs o17095816 primi 33w+2d 59.8 163 22.4 13 158 91 100 60 89 term nvd aga _ no no no
yazhini 30yrs o14007978 multi 32w+5dshort stature,mild anemia47 145 22.4 4 199 742 40 34 92 term nvd aga _ no no no
baby 23yrs o18029950 primi 33w+3d 56 156 22.4 7 164 182 112 46 104 term nvd aga _ no no yes
hariya dharshni 17yrs o18032293 primi 34w 56 156 22.4 6 178 145 117 60 95 preterm nvd aga _ no no yes
harshavarthini 28yrs o16006003 primi 34w+1d 65 170 22.5 18 180 158 113 54 123 term nvd aga _ no no no
rajeshwari 25yrs o18023406 primi 34w 43 147 22.6 7 202 334 122 45 105 term lscs sga _ no no no
kalaivani 23yrs o18000639 primi 32w+6d 50 158 22.7 10 167 129 117 43 111 term nvd aga _ no no no
balamahalakshmi21yrs o18063763 primi 33w+6doligohydrominos 50 151 22.7 14 249 164 181 64 103 term nvd sga _ no no no
sameem banu 22yrs o17083275 multi 33w previous lscs 54 154 22.8 7 168 126 94 66 87 preterm lscs sga _ no no yes
thahera 22yrs o17070927 primi 33w 67 171 22.9 7 186 105 105 82 95 preterm nvd sga _ no no no
vajeeha 18yrs o17073913 primi 34w 58 159 22.9 11 241 332 142 58 101 term nvd sga _ no no no
kanimozhi 26yrs o17097442 primi 33w+6d 60 162 22.9 6 192 337 115 44 94 term nvd aga _ no yes no
gomathi 22yrs o17089536 primi 33w+6d 58 159 22.9 11 224 125 166 60 121 term nvd aga _ no yes no
santhiya 23yrs o18003964 primi 33w+6dbronchial asthma 50.6 159 23 11 135 424 52 32 90 term nvd aga _ no no no
nagalakshmi 24yrs o18002567 primi 34w+1d 51 159 23.1 9 149 160 87 43 105 term nvd aga _ no yes no
surya 27yrs o18003362 primi 34w+1d 51 153 23.1 16 231 301 164 43 119 term lscs aga _ no no no
rizvana begam 25yrs o18010878 multi 32w+6d previous lscs 56 162 23.3 8.6 189 194 118 55 101 term lscs lga _ no no no
sreeja 23yrs o16004283 multi 33w+2d 63 170 23.3 10 198 120 139 60 109 term nvd aga _ no no no
vimala 24yrs o17053918 primi 33w+1dpolyhydromnios 62 163 23.3 16 172 137 115 52 103 term lscs aga _ no no no
subalakshmi 30yrs o15010006 multi 34w+1d prom 60 160 23.4 7 157 172 82 61 96 term nvd aga _ no no no
bharathi 21yrs o17057591 primi 32w+3d short stature 46.5 141 23.4 19 198 148 134 48 85 term nvd sga _ no no yes
sree lakshmi 27yrs o18015506 multi 33w+6d 50 146 23.5 10 251 195 174 69 130 term nvd aga _ no no no
vidhya 25yrs o17054003 primi 34w 50.8 146 23.5 15 250 162 192 52 134 term lscs sga _ no no yes
padmini 24yrs o14087500 multi 34w 52 157 23.6 11 132 193 78 34 136 term nvd lga _ no no no
sangeetha 34yrs o06048410 multi 32w+6d previous lscs 52.3 150 23.7 12 207 364 118 56 114 term lscs aga _ no no no
annam 23yrs o18014708 multi 32w+5d previous lscs 57 157 23.7 10 233 157 172 52 112 term lscs aga _ no no no
priyanka vinnarasi23yrs o17080504 primi 33w+6drh negative,low lying placenta61 160 23.8 10 205 199 120 67 112 preterm lscs sga _ no no no
ramya 26yrs o11095641 multi 32w 53 149 23.9 13 177 137 96 84 103 term nvd aga _ no no no
rajeshwari 28yrs o18043229 primi 33w+4d 60 165 24 11.2 267 256 185 63 130 term nvd aga _ no no no
sangeetha 22yrs o09049668 multi 32w+6danemia treated 55 151 24.1 10 244 231 161 59 115 term lscs aga _ no no no
kavitha 26yrs o18001868 primi 34w 56 153 24.3 10 129 233 181 77 109 preterm lscs sga _ yes no yes
lavanya 23yrs o17062482 primi 33w+4d 55 158 24.4 8 226 250 246 61 90 term lscs aga _ no no no
nivetha 23yrs o18004378 primi 33w+5d 53.8 154 24.4 13 234 181 173 65 106 term nvd aga _ no no no
indhira 24yrs o17064370 primi 34w+1d 55 150 24.4 17 209 121 126 82 85 term lscs aga _ no no no
devipriya 27yrs o18022397 primi 32w+5d rh negative 55.3 153 24.5 10 172 143 109 57 94 term lscs aga _ no no no
amala princy 27yrs o17094284 primi 34w+4doligohydrominos 54 156 24.5 12 181 182 113 61 123 term nvd aga _ no no no
pavithra 24yrs o17086593 primi 34w prom 66 164 24.5 9 200 158 129 68 118 term nvd aga _ no no no
ajim sapna 21yrs o18004517 multi 33w 54 149 24.54 6 207 124 147 52 90 term nvd aga _ no no no
jannathul 19yrs o18046280 primi 33w+6 52 145 24.7 10 171 284 112 30 89 term nvd sga _ no no no
mohana 25yrs o17080725 primi 32w+4d 60 156 24.7 9 222 296 134 67 137 term nvd aga _ no no no
dhivya 27yrs 10078377 multi 33w+3d 64 161 24.7 9 239 139 180 63 85 term nvd aga _ no no no
shobana 27yrs o18032593 primi 33w+6d 62 160 24.8 13 298 208 242 59 120 term nvd aga _ no no no
durga devi 32yrs o12091895 multi 34w asthma 66 163 24.8 9 221 226 144 48 108 term nvd aga _ no no no
nandhini 23yrs o17037244 primi 32w+6d 53 146 24.9 8 139 207 90 39 103 term nvd aga _ no no no
dyana kiruba 26yrs o16081284 primi 32w+1d 65 164 25 10 264 263 197 60 111 term nvd aga _ no no no
banu priya 23yrs o17062840 primi 32w+5d 61 156 25.0 12 232 251 164 49 110 term nvd aga _ no no no
MASTER CHART
NAME AGE OP NO. OBS SCORE GA CO MORB WEIGHT HT BMI WT GAIN TC TG LDL HDL GCT TERM/PRE NVD/LSCS BRT WT STILL BORNPRE ECLAM GDM IUGR
kaleeswari 23yrs o15060808 multi 33w+1d 48 149 25.2 8 173 500 64 51 128 term nvd lga _ no no no
nafila 20yrs o17003355 primi 33woligohydrominos, anemia treated59.7 154 25.2 7.9 270 236 200 64 105 term nvd aga _ no no no
priyadharshini 28yrs o14024736 multi 32w+4d 57.3 153 25.4 10 228 390 123 67 116 term nvd aga _ no no no
gayathri 27yrs o12077873 multi 33w+5d 56 157 25.4 11 233 155 165 64 96 term nvd aga _ no no no
karpagam 24yrs o18007432 primi 33w+4dpolyhydrominos,anemia56 159 25.4 15 267 357 175 62 120 preterm lscs aga _ no no no
aishwarya lakshmi 26yrs o17045040 multi 34w previous lscs 62.5 157 25.4 5 180 232 82 69 118 term lscs aga _ no no yes
sapnaparveen 25yrs o17097564 primi 32w+6d 60.8 156 25.6 10 169 234 100 45 88 term lscs aga _ no yes no
sathya priya 26yrs o18009512 multi 33w previous lscs 61.6 162 25.6 10 165 233 97 47 122 preterm lscs aga _ no no no
mythili 26yrs o17098405 primi 33w+6d 64 162 25.6 15 143 254 77 28 103 term nvd sga _ no no no
sasikala 24yrs o18003206 primi 33w+2d rh negative 58 150 25.7 12 205 165 136 67 69 preterm lscs sga _ no no yes
vinothini 28yrs o18004520 primi 33w+2d 58 155 25.7 12 190 387 96 47 116 term nvd aga _ no no no
anitha 29yrs o17063802 primi 32w+6d mild anemia 56.3 148 25.7 8 170 153 117 45 96 term nvd aga _ no no no
bharathi peter 22yrs o17087519 primi 34w 57 156 25.9 15 169 223 99 57 133 term nvd aga _ no no no
anitha 28yrs o13089114 multi 34w boh 57 159 25.9 10 300 219 223 71 97 term nvd aga _ no no no
subha 23yrs o17064940 primi 34w short stature 53 143 25.9 20 188 199 115 57 110 term lscs aga _ no no no
mubina 27yrs 18049573 primi 32w+6d 60 157 26.08 11 207 271 124 63 128 term nvd aga _ no no no
kowsalya 20yrs o18003366 primi 33w+3d 58 150 26.2 8 122 114 64 52 89 preterm nvd sga _ no no yes
silpika jyothi 28yrs o16016454 primi 32w+6d 50 147 26.3 6 195 346 96 49 123 term nvd aga _ no no no
athenesia mary 23yrs o18038814 multi 34w anemia 58 155 26.3 12 180 136 80 51 108 term nvd aga _ no yes no
sheeba rani 26yrs o18005421 primi 32w+6d 58 150 26.3 5 241 168 188 52 108 term nvd aga _ no no no
rashitha begam 23yrs o18006169 primi 32w+5d 50.2 145 26.4 14 206 226 139 51 118 term lscs aga _ no no no
kalpana 26yrs o18037946 primi 34w 64 157 26.6 10 271 186 161 116 83 term lscs aga _ no yes no
rafeeja 27yrs o16030335 multi 33w previous lscs 64 160 26.6 9 203 240 107 82 118 term lscs aga _ no yes no
ramya 28yrs o18037593 primi 33w+3d 80 174 26.6 16 227 146 164 61 115 term nvd aga _ no no no
sabreena 20yrs o14077064 multi 32w+6d previous lscs 70 162 26.7 6 261 244 185 55 120 preterm lscs aga _ no no no
karthika 27yrs o10065822 multi 33w 60 150 26.7 9 189 245 133 44 107 term nvd aga _ no yes no
nisanthi 28yrs o18014071 primi 32w+6d 67.2 164 26.8 15 218 189 157 53 103 term lscs aga _ no no no
ajeena 27yrs o18005488 multi 33w+1d 67 162 26.8 8 277 170 212 69 96 term nvd sga _ no no no
rose mary 26yrs o18008481 multi 34w 61 151 26.8 8 144 275 72 40 89 term nvd aga _ no no no
sathya 33yrs o12025357 multi 33w+6danemia treated 61 151 26.8 20 185 220 108 52 107 term nvd aga _ no no no
girija 24yrs o17098509 multi 33w previous lscs 64.6 160 26.9 6 226 333 162 36 98 term lscs lga _ no yes no
sahana jaffer 21yrs o18011000 primi 33w+1d ggi on diet 74 166 26.9 6 301 203 247 48 129 term lscs aga _ no no no
dhivya 31yrs o13068281 multi 33w+4d previous lscs 78.8 171 26.9 5 126 240 69 37 96 term lscs aga _ no yes no
enitha 21yrs o18000770 primi 34w+1d 69 160 27 8 202 259 131 44 88 term nvd aga _ no no no
ranjitha 24yrs o14083052 multi 33w 65 158 27 5 233 259 153 63 107 term nvd aga _ no no no
sathya priya 28yrs o18048102 primi 33w+3doligohydrominos 65 167 27.08 14 165 126 90 68 107 term lscs sga _ no no no
sumaiya parveen20yrs o18041752 primi 34w 60 156 27.2 17 240 142 186 58 94 term nvd aga _ no no no
kalavathi 28yrs o13047840 multi 33w+1d 60 158 27.2 8 234 191 170 57 103 term nvd aga _ no yes no
mymoon beevi 28yrs o18039041 multi 32w+5d previous lscs 60 150 27.2 9 192 164 137 45 107 term lscs aga _ no no no
firthose 25yrs o18009562 multi 33w previous lscs 60 150 27.2 10 186 197 126 49 86 term lscs aga _ no no no
amala 31yrs o12052684 multi 33w+2d 68 162 27.2 7 220 233 163 53 88 term nvd aga _ no no no
selva rani 28yrs o13019309 multi 33w+2d 60 158 27.2 8 234 242 169 40 124 term nvd aga _ no yes no
dhivya 25yrs o13091635 multi 33w+4d 71 164 27.3 13 162 155 95 57 119 term nvd lga _ no no no
rahamath nisha 25yrs o17083599 multi 33w+1d previous lscs 63 152 27.3 7 170 160 99 60 95 term lscs aga _ no no no
aparna 23yrs o18021382 primi 34wgestational protinuria69 159 27.3 18 153 137 95 44 104 term nvd sga _ no no no
saranya priya 29yrs o17068262 primi 34w 66 155 27.5 10 230 185 161 59 118 term nvd aga _ no no no
saranya priya 29yrs o17068262 primi 32w+6d 66 155 27.5 6 220 187 160 53 88 term nvd aga _ no no no
sameena 31yrs o18041176 multi 33w+5d 60.5 155 27.5 18 198 162 134 58 85 term nvd aga _ no no no
apparna christy 24yrs o17081849 primi 33w+5d 61.4 151 27.9 15 221 178 139 75 103 term nvd aga _ no no no
lalitha mani 22yrs o16079351 multi 33w+4d 70 161 28 9 212 149 152 49 106 term nvd aga _ no no no
nithya devi 32yrs o13050160 multi 33w previous lscs 62 156 28.1 10 212 136 157 54 98 term lscs aga _ no yes no
sapnaparveen 21yrs o13046261 multi 32w+6d 68 164 28.3 8 212 163 135 69 130 term nvd aga _ no yes no
maria hillga 23yrs o14035878 primi 33w+1d 71 158 28.4 10 180 178 88 85 144 term nvd aga _ yes yes no
ramya 33yrs o18037593 primi 33w+1d 80 174 28.5 14 227 146 164 61 115 term nvd aga _ no no no
suganthi 21yrs o15023991 primi 34w 73 160 28.5 5 190 167 142 39 93 term nvd aga _ no no no
radha 32yrs o17017274 primi 32w+3d short stature 57 143 28.5 10 242 169 177 42 131 term nvd aga _ no yes yes
bhuvaneshwari 24yrs o18032449 primi 33w+2d 66 153 28.6 10 160 198 83 62 76 term nvd aga _ no yes no
madhavi 24yrs o15007526 multi 33w+3d 69 156 28.7 11 218 251 148 64 119 term nvd aga _ no no no
bhuvaneshwari 29yrs o18024981 primi 34w allergic bronchitis 62 157 28.8 13 226 260 126 78 109 term nvd aga _ no no no
sumithra devi 30yrs o18024531 multi 32w+6d prom 72 165 28.8 13 267 244 189 80 115 term nvd lga _ no no no
dhivya 24yrs o17072338 primi 33w 71 157 28.8 11 176 144 104 59 95 term nvd aga _ no no no
santhiya 25yrs o16072217 multi 34w 55 145 28.9 10 223 223 150 57 110 term lscs aga _ no no no
navaneetha 21yrs o14000514 multi 32w+4d 70 163 29.16 9 223 225 151 55 124 term nvd aga _ yes yes no
harshini 26yrs o15017194 multi 33w+6d 82 171 29.2 6 189 147 125 56 90 term nvd aga _ no no no
vijaya 29yrs o18009255 primi 32w+1d 72 156 29.6 6 169 227 95 52 93 term nvd aga _ no no no
anitha 21yrs o17086714 primi 32w+5d 87 158 34.9 9 228 203 155 55 94 term nvd aga _ no no no
benazir 22yrs o170303776 primi 32w+2d 75 158 31.25 9 193 397 113 44 135 term nvd aga _ no yes no
dhanalakshmi 21yrs o18011996 primi 34w breech 78 157 32.5 20 210 233 148 48 105 term lscs aga _ no no no
kanneswari 34yrs o18021216 multi 32w+4dprevious lscs, rh neg pregnancy80 165 33.3 19 170 113 114 57 140 term lscs aga _ no yes no
karpaga valli 31yrs o18038820 primi 33w+2d gdm on diet 72 155 33.6 10 238 151 164 64 100 term lscs aga _ no yes yes
kathambari 28yrs o18034689 primi 32w+6doligohydrominos 74 156 33.6 9 205 195 132 58 104 preterm nvd sga _ no no no
keerthana 21yrs o16068062 primi 33w+5d 66 148 30.1 13 201 207 128 60 115 term lscs aga _ no no no
manimekalai 33yrs o12028100 multi 32w previous lscs 67 153 30.4 12 245 293 184 43 106 term lscs aga _ no no no
masilamani 30yrs o15077551 multi 33wprevious lscs, short stature61 142 30.3 11 144 160 68 68 113 term lscs aga _ no no no
monisha 25yrs o18013269 primi 33w+6d 75 160 31.25 8 261 279 197 46 131 term nvd aga _ no yes no
nagarathinam 33yrs o18022718 multi 33w+1d 74 158 33.6 10 240 159 140 99 98 preterm nvd aga _ yes no no
premalatha 28yrs o17095711 primi 34w+2d 60 146 31.5 9 306 256 233 74 107 term lscs aga _ no no no
priyadharshini o17045369 primi 33w+1d 77 154 33.4 8 197 219 134 56 120 term nvd aga _ no yes no
rahamath beevi 32yrs o18006204 multi 33w+1d 64 149 33.6 6 174 219 106 47 110 term nvd aga _ no yes no
ruhina 27yrs o15006738 multi 32w+3d 77 160 30.1 9 167 235 94 56 109 preterm nvd aga _ no yes no
swetha 25yrs o18024677 primi 33w+4d 81 163 32.4 12 130 154 152 73 71 term nvd lga _ no no no
thaslima 17yrs 18025793 primi 33w+4d 78 162 32.5 18 188 90 146 44 107 term nvd aga _ no no no
vinotha 34yrs o13039667 multi 33w+4d previous lscs 67.3 156 30.59 8 246 178 167 72 105 term lscs aga _ no no no
prabhavathy 30yrs o18057685 multi 34w 62 156 12 189 132 111 76 102 term nvd aga _ no no no
